Table of Contents Table of Contents
Previous Page  23 / 34 Next Page
Information
Show Menu
Previous Page 23 / 34 Next Page
Page Background

Doxo 75 vs Doxo+Conatumumab

Phase I/II R

´

G. Demetri Eur J Cancer (2012) 48, 547– 563